Analyst Research
| Report Title | Price |
|---|---|
|
Trading Report for (MDT). A detailed report, including free correlated market analysis, and updates.
Provider: Stock Traders Daily
|
$58.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Medtronic Inc Issues FY 2013 Guidance In Line With Analysts' Estimates
Medtronic Inc announced that for fiscal 2013, it expects revenue growth in the range of 2% to 4% on a constant currency basis. The company expects fiscal 2013 diluted earnings per share (EPS) in the range of $3.62 to $3.70, which implies EPS growth of 5% to 7%. The Company reported revenue of $16.184 billion in fiscal 2012. According to I/B/E/S Estimates, analysts were expecting the Company to report revenue of $16.525 billion and EPS of $3.66 for fiscal 2013.
Latest Developments for Medtronic Inc
- Medtronic Inc's In.Pact Falcon Drug-Eluting Balloon Yields Positive Outcomes in Small Coronary Arteries
- Medtronic Inc Issues FY 2014 Guidance; EPS Guidance Above Analysts' Estimates-Conference Call
- Medtronic Inc Receives 'CE' Mark for 'Export Advance' Aspiration Catheter
- Medtronic Inc Reaffirms FY 2013 Revenue Guidance-Conference Call
- Share this
- Link this
- Digg this
Follow Reuters